Skip to content
healthcare.dev

Pregabalin Extended Release

NDC 50228-464, PREGABALIN, tablet, film coated, extended release, from ScieGen Pharmaceuticals, INC..

Product NDC
50228-464
Status
Listed
Labeler
ScieGen Pharmaceuticals, INC.
Dosage form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA215675
DEA schedule
CV
Request
curl https://api.healthcare.dev/v1/drugs/ndc/50228-464 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • PREGABALIN330 mg/1
Package NDCNDC-11Package
50228-464-0550228046405500 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-464-05)
50228-464-305022804643030 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50228-464-30)

Linked data

RxNorm, label and prices

RxNorm concepts

Related lookups

  • FDA label sections

    GET /v1/drugs/labels/1544a657-353c-47f8-96ac-a63fa78373f0

Use it

Look up 50228-464 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/50228-464 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 50228-464. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.